pathology-congress-2017-keynote

3 / 7

Volume 7, Issue 5 (Suppl) J Clin Exp Pathol
ISSN: 2161-0681 JCEP, an open access journal Pathology Congress 2017
November 13-14, 2017
Page 12
conferenceseries.com
NOVEMBER 13-14, 2017 OSAKA, JAPAN
14th Asia Pacific Pathology Congress
Fracture analysis and assessment: From materials to large-scale steel structures
Fracture failure has emerged as one of the most common failure modes in modern large-scale steel structures subjected
to cyclic or extreme loads caused by artificial or environmental actions. The integrity assessment of the fracture requires
a detailed understanding on the mateThe Australian National Cervical Cancer Screening Program commenced in 1982 and
has reduced the incidence of cervical cancer from 20 per 100,000 women to 9 per 100,000 in 2010. The rate of reduction of
cancers has leveled off and remained relatively unchanged since 2010. In 2007, a National HPV Vaccine program for girls and
young women was commenced and in 2009 it became school based and expanded to include boys. Up-take of the quadrivalent
vaccine is in the region of 85% and the incidence of HPV-related high-grade lesions has fallen in the vaccinated population.
There has been a reduction in prevalence of high-grade lesions in older unvaccinated women, suggesting a herd-immunity
effect. With the reduced incidence of cervical lesions, detection of abnormal smears on conventional Papanicolaou smears
will become more difficult. In the HPV vaccine era, a more sensitive and specific test with a high negative predictive value
is needed, predicating a change to HPV DNA testing. Numerous studies have shown that HPV DNA testing with partial
genotyping confers the most cost-effective and effective means of population based cervical screening. The Renewed Cervical
Screening Program commences in December 2017. Implementation of a new National Cancer Screening Register will change
the way women are invited to screening or recalled for follow-up and will reduce under-screening. A new initiative to screen
woman who for cultural or other reasons have not been screened, will enhance the efficacy of the program. A further reduction
of the incidence of cervical cancer in Australia is anticipated.
Biography
Bryan Knight was trained at the Godfrey Huggins School of Medicine and was qualified in Pathology and has obtained his PhD at the University of Cape Town. He
has practiced in Cape Town for 20 years and was a Lecturer at UCT and Director of the Yvonne Parffitt Cytology Laboratory. He has also worked in Canada, where
he was Associate Professor of Pathology in Edmonton, Alberta, then Laboratory Director at the BC Cancer Agency in Vancouver.
Bryan Knight
Southern IML Pathology, Australia
Bryan Knight, J Clin Exp Pathol 2017, 7:5 (Suppl)
DOI: 10.4172/2161-0681-C1-039